CPT® Code 90661

Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

The CPT® Code 90661 refers to the influenza virus vaccine, specifically a trivalent formulation known as ccIIV3. This vaccine is derived from cell cultures and is designed to provide active, long-term immunity against influenza. Unlike immune globulins, which offer short-term, passive immunity, vaccines stimulate the recipient's immune system to produce its own antibodies. This process involves exposing the immune system to altered versions of specific viruses, prompting it to recognize and remember how to combat these pathogens in the future. The trivalent nature of this vaccine means it contains components from three different influenza viruses: two strains of influenza type A and one strain of influenza type B. A notable feature of this vaccine is that it is antibiotic-free, produced in a sterile environment without the use of antibiotics, which distinguishes it from other influenza vaccine formulations. The dosage for this vaccine is 0.5 mL, and it is intended for intramuscular use. It is important to note that the administration of this vaccine via intramuscular injection is reported separately from the vaccine code itself.